Travere Therapeutics, Inc. (TVTX) › Total LiabilitiesTravere Therapeutics, Inc. (TVTX) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2012: $5.80M2013: $40.17M2014: $172.72M2015: $212.29M2016: $217.51M2017: $227.21M2018: $390.91M2019: $383.60M2020: $396.23M2021: $474.52M2022: $629.73M2023: $588.10M2024: $535.05M2025: $490.36M$490.36M2012Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$490.36M-8.4%2024$535.05M-9.0%2023$588.10M-6.6%2022$629.73M+32.7%2021$474.52M+19.8%2020$396.23M+3.3%2019$383.60M-1.9%2018$390.91M+72.0%2017$227.21M+4.5%2016$217.51M+2.5%2015$212.29M+22.9%2014$172.72M+330.0%2013$40.17M+592.6%2012$5.80M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share